Document is current
Any future updates will be listed below
-
Authors
Gonzalez, Trevor J.
Mitchell-Dick, Aaron https://orcid.org/0000-0001-6730-8868
Blondel, Leo O. https://orcid.org/0000-0002-9211-259X
Fanous, Marco M.
Hull, Joshua A.
Oh, Daniel K.
Moller-Tank, Sven
Castellanos Rivera, Ruth M.
Piedrahita, Jorge A.
Asokan, Aravind https://orcid.org/0000-0001-5563-4877
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL089221, R01HL089221, R01HL089221, R01HL089221, R01HL089221, R01HL089221, R01HL089221)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (UH3AR075336, UG3AR07336, UG3AR07336, UH3AR075336, UH3AR075336, UG3AR07336, UG3AR07336, UH3AR075336)
- License Information
-
More Information
Article History
Received: 21 July 2022
Accepted: 13 June 2023
First Online: 21 September 2023
Competing interests
: T.J.G. and A.A. have filed patent applications on the subject matter of this paper. A.A. is a co-founder at StrideBio and TorqueBio and serves on the advisory boards of Atsena Therapeutics, Isolere Bio, Mammoth Bio, Ring Therapeutics and Kriya Therapeutics. S.M.-T. is a current employee of Regeneron Pharmaceuticals. R.M.C.R. is a current employee of Kriya Therapeutics.
